To identify sequence variants in genes that may have roles in neuronal responses to alcohol, we resequenced the 5 0 region of tyrosine kinase B neurotrophin receptor gene (NTRK2) and determined linkage disequilibrium (LD) values, haplotype structure, and performed association analyses using 43 single nucleotide polymorphisms (SNPs) covering the entire NTRK2 region in a Finnish Caucasian sample of 229 alcohol-dependent subjects with antisocial personality disorder (ASPD) and 287 healthy controls. Individually, three SNPs were associated with alcohol dependence and alcohol abuse (AD) (P-value from 0.0019 to 0.0059, significance level was set at Pp0.01 corrected for multiple testing), whereas a common 18 locus haplotype within the largest LD block of NTRK2, a 119-kb region containing the 5 0 flanking region and exons 1-15, was marginally overrepresented in control subjects compared to AD individuals (global P ¼ 0.057). Taken together, these results support a role for the NTRK2 gene in addiction in a Caucasian population with AD and a subtype of ASPD.
Introduction
Alcohol dependence (AD) (MIM 103780) is a common complex addiction having a heritability of at least 50%, in both men and women. 1 Approximately, 7% of the adult US population (about 18 million individuals) is diagnosed with alcohol abuse or dependence. 2 Vulnerability to alcoholism is most likely due to multiple interacting genes, each having a modest contribution to the phenotype and gene-environment interactions. Understanding the contribution of allelic variation to AD will aid in defining neurochemical pathways that are altered in the brain to produce addiction and to better understand mechanisms that may be shared with other habit-forming behaviors in humans, such as cigarette smoking. 3 Candidate gene studies and linkage-based genome scans have identified multiple chromosomal regions as sources of potential susceptibility to AD as well as other addictions, showing some convergent findings. 4 Examples of this convergence are the genes encoding alcohol dehydrogenase IB (ADH1B) and aldehyde dehydrogenase 2 (ALDH2), which were originally based on the mechanism of the association of ADH1B and ALDH2 polymorphisms with AD in that the isoenzymes encoded by these alleles lead to an accumulation of acetaldehyde during alcohol metabolism. In other investigations of interest to the current study, cigarette smoking with or without AD, were linked to broad regions of chromosomes 9 and 11. [4] [5] [6] [7] [8] [9] Among the candidate addiction susceptibility genes defined by these linkage signals were those that encode the neurotrophin, brainderived neurotrophic factor (BDNF, chromosome 11), and its cognate receptor, neurotrophic tyrosine kinase receptor B (TrkB) (NTRK2, chromosome 9).
Neurotrophins are a family of developmentally regulated proteins that are critical for differentiation and survival of post-mitotic neurons and in synaptic plasticity. The biological activity of neurotrophins is mediated by the Trk family of receptors having intrinsic protein-tyrosine kinase activity, 10 but with different binding affinities for neurotrophins. High-affinity binding and receptor activation by BDNF is mediated by TrkB. BDNF binding to TrkB results in receptor dimerization and trans-autophosphorylation of tyrosine residues in the carboxyl-terminal intracellular domain that is required for activation of signaling cascades, which include transcriptional activation of the BDNF gene (BDNF). 11 At least three protein isoforms of TrkB are produced by alternative splicing of NTRK2 pre-mRNAs. These isoforms are the full-length tyrosine kinase receptor, an isoform lacking the tyrosine kinase domain (TrkB-T1), and an isoform lacking the tyrosine kinase domain but containing a Shc binding site (TrkB-T-Shc). 12 All three isoforms are expressed in brain. The T1 isoform has dominant inhibitory effects on BDNF-mediated signaling, although the cellular and molecular functions of truncated TrkB isoforms are not well understood. [13] [14] [15] [16] However, there is accumulating evidence that truncated TrkB isoforms have both dominant-negative inhibitory activity on full-length TrkB receptors and yet are capable of mediating signal transduction independent of full-length TrkB receptors. 14, 15, 17, 18 Evidence supporting a role for BDNF signaling in mechanisms of alcohol and drug dependence has been well documented using different animal models. For example, McGough et al. 19 showed that in BDNF-deficient mice, decreased levels of BDNF lead to increased ethanol sensitization and increased voluntary ethanol consumption after a 2-week withdrawal compared to wild-type animals. In addition, this group showed that when wild-type C57BL/6 mice were allowed to self-administer ethanol, having unlimited access to both water and a 10% ethanol solution for 4 weeks, BDNF mRNA levels were significantly increased in dorsal striatum, a brain region associated with motor control. These results suggest that BDNF signaling is part of regulatory pathway that may offset the development of dependence by limiting alcohol intake. This concept was supported by a previous report using rats that received an infusion of BDNF into the ventral tegmental area, preventing drug-induced adaptations in a brain region known to be involved in drug reinforcing behavior. 20 The essential functional role of BDNF in TrkB-mediated signaling was demonstrated in a model of neurodegeneration, where survival of hippocampal neurons in culture derived from trisomy 16 mice, which produce the truncated kinasedeficient isoform, Trk-T1, and would be destined to die were restored by introduction of exogenous full-length TrkB. 21 A role for TrkB linked to AD in humans has not been reported. In the present study, we found evidence for allele-, genotype-and haplotype-based association of NTRK2 with AD, antisocial personality disorder (ASPD) type, in a Finnish population. These data provide evidence for a new role of TrkB in addictive disorders. As a first approach to identifying sequence variants that may control NTRK2 expression, we also resequenced the 5 0 region of NTRK2.
Results
Identification of NTRK2 sequence variants in the 5 0 region Resequencing of the 5 0 region of NTRK2 in a clinically and ethnically diverse sample of 190 unrelated individuals uncovered two novel sequence variants (LNG5 and LNG7; Table 1 ). The two previously unknown single nucleotide polymorphisms (SNPs) were located within intronic sequences. Five of the seven variants were previously known LNG1  rs1212171  HCV7424025  C4T  promoter  84 512 081  LNG2  rs3758317  HCV3237595  C4T  promoter  84 512 169  LNG3  rs1187321  HCV7424024  A4T  promoter  84 512 585  LNG4  NR   b   HCV27838439  G4A  promoter  84 513 300  LNG5  NR  NR  A4G  intron 4  84 514 790  LNG6  rs1187325  hCV3237596  G4C  5  0 -UTR exon 5  84 515 149  LNG7  NR  NR  T4C  intron 5  84 515 Table 2 shows the SNP markers used in the current study. Genotypes were obtained from a total of 43 SNP markers and were tested for meeting Hardy-Weinberg equilibrium (HWE) expectations in the case and control groups, respectively. All SNPs fit HWE in each group (P40.05) with the exception of SNP19 (P ¼ 0.042) and SNP32, (P ¼ 0.045), which showed marginally significant departures from HWE. These two markers were excluded from subsequent analyses.
Hardy-Weinberg equilibrium test

SNP association
Genotypes were obtained for each of the 43 SNPs, spanning 363 kb of the NTRK2 gene (Figure 1a) , and analyzed for allelic and genotypic association. For two markers, strong significant allelic association with AD was observed (P ¼ 0.0041 for SNP5 and P ¼ 0.0019 for SNP30) ( Table 3 ). SNP4 and SNP30 showed genotypic association with AD after multiple test correction (Pp0.01) ( Table 3) .
Linkage disequilibrium of NTRK2 gene Figure 1b shows [20] [21] [22] and these markers were in complete LD. Block 5 was composed of seven SNPs from SNP37 to SNP43, encompassing exons 23 and 24 with 8 SNP pairs in complete LD. Haplotype structure and frequency were estimated within each block separately for case and control groups.
Haplotype-based association with AD Haplotypes with frequencies greater than 0.03 in each LD block are listed Table 4 . In LD block1, eighteen loci generated five haplotypes with frequencies greater than , haplotype 3A contained allele 1 of SNP30 and was at slightly higher frequency in the control group (0.503) than in AD subjects (0.424) (w 2 ¼ 5.858, P ¼ 0.015, corrected P ¼ 0.062), whereas haplotype 3B, which included allele 2 of SNP30, was more abundant in the AD group than the control group, supporting the prior single allele association with SNP30. Haplotype block 4 contained only two loci and generated two major haplotypes (4A and 4B). The frequency of haplotype 4B was 0.246 in the AD group, whereas it was represented at lower frequency (0.192) in the controls (w 2 ¼ 3.988, P ¼ 0.046, corrected P ¼ 0.092). Taken together, these results support an association of the NTRK2 gene with AD, using both single locus and haplotype-based approaches.
Discussion
The current study provides supportive evidence for an association between variation at NTRK2 and AD. Evidence of association of the NTRK2 gene with AD was gained using both single locus and haplotype-based approaches. In this population, composed of Finnish Caucasians, three markers, of a total of 43 that were genotyped showed significant genotypic/allelic association with AD. Of note was the fact that two of these markers (SNPs 4 and 5) are located to the 5 0 end of NTRK2, suggesting that this region may participate in AD directly or indirectly. Moreover, the haplotype-based association results supported overrepresentation of the 1A haplotype in the control sample, suggesting the presence of a low-risk haplotypes in AD.
An additional finding from this study was the pattern of LD across NTRK2 in a Finnish Caucasian population. Overall LD was strong across the 353 kb region, and five LD blocks were observed. The HapMap Project generated data on genome-wide levels of variation in different human populations with the intent of guiding the design and analysis of medical genetic studies. 22 We used publicly available genotyping data from HapMap Public Release no. 20 to compare patterns of LD between the Centre d'Etude du Using these values of LD from the CEU panel, we were able to observe a similar block-like structure that was visually apparent in Figure 1b (QY and KX, unpublished data). Five LD blocks from the Finnish sample were observed although only 41 SNPs were used in this study, suggesting that the SNPs selected were sufficient to represent the 'true' LD structure in this region and that the block structure was not an artifact of either low marker density or marker selection. 23 To compare haplotype configuration and frequency between CEU and the Finnish samples, we constructed haplotypes using shared SNPs between those used in the HapMap project and this study (26 markers, Table 2 ). In our analyses, we only considered those haplotypes with a frequency 40.03. We found that haplotype structure and haplotype frequencies were very similar between the two samples ranging from the largest region of LD, Block 1 to the smallest, composed of Block 4. Overall, these results indicate that the block structure and haplotypes within the NTRK2 region are well conserved between the CEU sample and the Finnish sample. When we initiated this study, HapMap data for the NTRK2 region was not available, but such cross-comparisons are essential for designing association studies. 23 It is the long-term remodeling of neuronal circuitry that is thought to underlie development of addictive behaviors, including AD. 24 BDNF is well known to be essential for neuronal survival, protection and activity-dependent synaptic remodeling. BDNF signaling, via TrkB, may alter the expression of target genes related to limiting alcohol of AD. 19 Variation in NTRK2 affecting expression of fulllength or truncated isoforms or their stability could profoundly affect this negative regulatory pathway. Thus, during chronic alcohol exposure, individuals with decreased TrkB-mediated signaling may be at greater risk of becoming AD.
Chronic alcohol exposure has been reported to decrease BDNF mRNA levels in the dentate gyrus and CA1 region of hippocampus, 25 although these findings were not supported by subsequent experiments. 26 Global levels and regionspecific levels of TrkB (rat TrkB) mRNA following chronic alcohol exposure were also determined. Levels of TrkB mRNA levels were increased in the hippocampus of rats exposed to chronic ethanol, as determined by an RNase protection assay, 25 although this was not observed using a semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) assay. 26 These disparate findings may be due to the fact that different treatment conditions were performed on different rat strains and different detection methods were used for determining BDNF mRNA levels. Future studies are required to refine treatment conditions and expression assays. With these issues in mind, TapiaArancibia et al. 25 observed an increase in TrkB mRNA levels in the hypothalamus from chronic alcohol exposed rats, a brain region known to be associated with satiety. BDNF-deficient mice exhibited increased eating behavior that was transiently reversed when BDNF was infused. 27 Thus, increased TrkB expression or TrkB-mediated signaling may serve as a negative regulatory pathway involved in food This study has a number of strengths and limitations. We used a relatively large number of SNP markers to capture as much variation as possible across NTRK2. Because of this, we were able to perform allele-, genotype-and haplotypebased analyses. However, although these association results did not include any known functional variants, they suggest regions of the gene that should have priority in searching for functional variants, particularly the 5 0 end of NTRK2. In addition, other methodological issues are of concern, where the application of a Bonferroni correction, taking into account the AD phenotype and 43 different markers may be too stringent for detecting the influence of a single gene predicted of having a modest effect in a complex disease such as AD where multiple genes are thought to have an influence. We think that 'overcorrecting' the data is a concern justified by the fact that strong LD exists among the different NTRK2 markers and that the LD blocks themselves are not independent factors, which negates use of a statistical correction. However, as a compromise, we performed a statistical correction by using the number of LD blocks covering this gene for single SNP association tests and presented a global P-value, taking into account multiple tests for haplotype-based association.
Regarding clinical characteristics, because 71% of the AD subjects in this study were also diagnosed with ASPD, there is a possibility that variation at NTRK2 may also play a role in the course of the disease and not just vulnerability to AD. A plausible functional relationship between alterations in neurotrophin signaling, which would largely occur through TrkB, and comorbid phenotypes with alcoholism has been recently reported by Matsushita et al., 29 who found that the A allele of the G196A (Val66Met) BDNF polymorphism was associated with alcoholic subjects having violent tendencies. However, a smaller study involving 110 AD Chinese convicts with violent histories did not support an association of BDNF Val66Met with ASPD comorbidity. 30 Additional studies will be necessary in different clinical populations to determine if variation at NTRK2 is associated with ASPD itself, or may modify phenotypes that are comorbid with AD.
To our knowledge, this is the first report of NTRK2 association with AD. Although our initial resequencing effort was confined to the 5 0 -flanking region, it uncovered two previously unknown SNPs. One of these sequence variants (SNP2) is located between two alternative 5 0 -UTR exons, whereas the other (SNP4) is located within intron 5, which is 3 0 of the first coding exon. Their functional impact on NTRK2 regulation is not known. As suggested above, future studies will focus on replicating these preliminary findings in other populations, identifying additional sequence variants in affected individuals that may lead to changes in NTRK2 regulation or TrkB function, and characterization of candidate functional SNPs in different contexts, in vitro and in vivo in order to better understand how alterations in TrkB expression or function impacts alcohol response-related phenotypes.
Materials and methods
Screening for sequence variants
To identify potentially functional sequence variants in the 5 0 region of NTRK2, 3.4 kb of the gene was analyzed in 190 unrelated individuals. The genomic region screened included five known exons in the 5 0 -UTR and flanking sequence, comprising 3.1 kb of genomic DNA relative to the translation start site. 12 The 'resequencing' sample was composed of 40 African Americans, 40 Finnish Caucasians and 110 US Caucasians. The sample was clinically diverse and included co-morbid conditions, composed of individuals with anxiety disorders (n ¼ 35), major depression (n ¼ 35), anorexia nervosa (n ¼ 20), obsessive-compulsive disorder (n ¼ 20), ASPD(n ¼ 40), suicidal behavior (n ¼ 40) and AD (n ¼ 110). DNA samples were obtained from cultured white blood cells from repositories. The resequencing strategy based on dHPLC and direct sequence analysis was described previously. 31 PCR samples with differential dHPLC elution profiles were selected for direct sequence analysis. Typically, the 10 ml sequencing reaction mixture contained 4 ml BigDye Terminator RR Mix (Applied Biosystems, ABI, Foster City, CA, USA); 2.84 ml of dH 2 O; 1.6 pmol of forward or reverse primer and 3 ml of purified PCR amplicon. Cycle conditions for sequencing were 25 cycles consisting of denaturation at 961C for 10 s, annealing at 501C for 5 s and extension at 601C for 4 min. Sequencing reaction products were purified by ethanol precipitation, dried, diluted with 25% formamide (v/v), denatured at 951C for 5 min and analyzed on a 3100 sequencer (ABI, Foster City, CA, USA).
Subjects
The sample Finnish Caucasian population has been described in detail elsewhere. 32 A total of 516 psychiatrically interviewed subjects included 229 alcoholics and 287 healthy controls were recruited under a human research protocol approved by the National Institutes of Health, Bethesda, MD, the University of Helsinki Department of Psychiatry institutional review board, Helsinki, Finland; and the University of Helsinki Central Hospital institutional review board. All subjects provided written informed consent.
All subjects were interviewed by two senior psychiatrists using The Structured Clinical Interview for DSM-III-R (SCID) 33 and were diagnosed using DSM-III-R criteria. The AD and alcohol abuse subjects were all male criminal offenders undergoing forensic psychiatric evaluation as inpatients in the Department of Psychiatry, University of Helsinki. Therefore, this population was enriched for ASPD and type II alcoholism, which was characterized as alcoholism with ASPD. 34 Among 229 cases, 71% individuals were AD with ASPD. The 287 unaffected controls were unrelated healthy Finnish male volunteers recruited through local newspaper advertisements.
SNP selection and genotyping
A total of 43 SNP loci from NTRK2 were selected for genotyping. The markers covered the entire NTRK2 region with a mean distance of 8796 kb (75992 kb) between markers. Genotyping was performed by using 5 0 -nuclease assays (TaqMan, Applied Biosystems, Foster City, CA, USA). The allele-specific detection probes and primers for each SNP were designed using Assays-by-Design software (ABI) or were order as Assays-on-Demand. Assay identification numbers are available on request. Approximately, 5 ng DNA from each sample was plated in 384-well format plates for genotyping with 10% randomly duplicated samples for detecting genotyping error. Genotyping was performed using an Applied Biosystems 7900 Sequence Detector with a 384-well plate format. Three genotype groups were consistently obtained for each biallelic marker based on its relative fluorescence intensity and analyzed by SDS software, version 2.2 (ABI). To access genotype accuracy genotypes were duplicated in approximately 10% of the samples and were randomly selected. Overall genotyping accuracy was 99% with greater than 95% of genotypes completed.
Statistical analyses for LD, single SNP association and haplotype-based association LD was estimated based on the formula: D ¼ P ab ÀP ax P b . D is LD; P ab is the haplotype expectation frequency at loci A and B. The terms P a and P b are allele frequencies at two loci. D 0 is normalized by the maximum value of possible D. LD was estimated using the Haploview program. 35 If D 0 -values are X0.98, there is little evidence for historic recombination. Thus, the two markers are considered to be in 'strong LD'. 36 An LD block was defined according to Gabriel's definition that less than 5% of comparisons among informative SNP pairs show strong evidence of historic recombine. Five regions of NTRK2 showed strong LD and were defined as LD blocks.
Genotype and allele frequencies were compared between AD and unaffected control subjects using standard w 2 tests. Because pairwise LD values were high across five regions of the NTRK2 region, multiple test correction was applied based on five LD blocks. The significance level was set as Pp0.01. Haplotype structure and frequency within the LD block were inferred separately by case and control groups by means of PHASE, which is a program based on a Bayesian algorithm. 37 The P-values of haplotype-based associations for each block were corrected by the number of haplotypes within the block.
